Pieris Pharmaceuticals Statistics
Total Valuation
PIRS has a market cap or net worth of $21.20 million. The enterprise value is $1.84 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PIRS has 1.32 million shares outstanding. The number of shares has increased by 21.29% in one year.
| Current Share Class | 1.32M |
| Shares Outstanding | 1.32M |
| Shares Change (YoY) | +21.29% |
| Shares Change (QoQ) | +1.62% |
| Owned by Insiders (%) | 1.36% |
| Owned by Institutions (%) | 15.36% |
| Float | 762,835 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.07 |
| Forward PS | 19.45 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.82
| Current Ratio | 4.82 |
| Quick Ratio | 4.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -68.21% and return on invested capital (ROIC) is -38.30%.
| Return on Equity (ROE) | -68.21% |
| Return on Assets (ROA) | -28.31% |
| Return on Capital (ROIC) | -38.30% |
| Revenue Per Employee | $27,040 |
| Profits Per Employee | -$319,060 |
| Employee Count | 50 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.33% in the last 52 weeks. The beta is 0.66, so PIRS's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -11.33% |
| 50-Day Moving Average | 16.55 |
| 200-Day Moving Average | 13.80 |
| Relative Strength Index (RSI) | 44.34 |
| Average Volume (20 Days) | 37,632 |
Short Selling Information
The latest short interest is 22,495, so 1.70% of the outstanding shares have been sold short.
| Short Interest | 22,495 |
| Short Previous Month | 26,825 |
| Short % of Shares Out | 1.70% |
| Short % of Float | 2.95% |
| Short Ratio (days to cover) | 3.52 |
Income Statement
In the last 12 months, PIRS had revenue of $1.35 million and -$15.95 million in losses. Loss per share was -$12.53.
| Revenue | 1.35M |
| Gross Profit | -40.45M |
| Operating Income | -18.10M |
| Pretax Income | -16.25M |
| Net Income | -15.95M |
| EBITDA | -18.30M |
| EBIT | -18.10M |
| Loss Per Share | -$12.53 |
Full Income StatementBalance Sheet
| Cash & Cash Equivalents | 19.36M |
| Total Debt | n/a |
| Net Cash | 19.36M |
| Net Cash Per Share | $14.62 |
| Equity (Book Value) | 16.27M |
| Book Value Per Share | 12.32 |
| Working Capital | 16.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$28.00 million and capital expenditures $13,000, giving a free cash flow of -$27.99 million.
| Operating Cash Flow | -28.00M |
| Capital Expenditures | 13,000 |
| Free Cash Flow | -27.99M |
| FCF Per Share | -$21.13 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,338.54% |
| Pretax Margin | -1,179.96% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -122.03% |